
Sign up to save your podcasts
Or


In this week’s VJOncology podcast, we had the opportunity to attend the 2026 British Thoracic Oncology Group (BTOG) conference, where we explored key developments in lung cancer screening, diagnostics, and clinical research. Join Robert Rintoul, University of Cambridge, Cambridge, UK, Lauren Dixon, London School of Hygiene & Tropical Medicine, London, UK, Mariana Brandao, Jules Bordet Institute, Brussels, Belgium, and Anna Bibby, North Bristol NHS Trust, Bristol, UK as they discuss national screening updates, insights from the State of the Nation report, ongoing EORTC trials, and the clinical implications of incidental findings in lung cancer screening programs.
By VJOncology5
22 ratings
In this week’s VJOncology podcast, we had the opportunity to attend the 2026 British Thoracic Oncology Group (BTOG) conference, where we explored key developments in lung cancer screening, diagnostics, and clinical research. Join Robert Rintoul, University of Cambridge, Cambridge, UK, Lauren Dixon, London School of Hygiene & Tropical Medicine, London, UK, Mariana Brandao, Jules Bordet Institute, Brussels, Belgium, and Anna Bibby, North Bristol NHS Trust, Bristol, UK as they discuss national screening updates, insights from the State of the Nation report, ongoing EORTC trials, and the clinical implications of incidental findings in lung cancer screening programs.